2 results
Approved WMOCompleted
To evaluate the safety, tolerability and efficacy of 3 doses of vernakalant (oral) (150 mg, 300 mg and 500 mg b.i.d.) administered for up to 90 days in subjects with sustained symptomatic atrial fibrillation (AF duration > 72 hours and &…
Approved WMORecruiting
The aim of this prospective randomized, double blind study is to evaluate the analgesic effects of pre-operative PECS II-block with (long-acting) liposomal Bupivacaine versus (short-acting) Levobupivacaine for patients undergoing a mastectomy.